@article {Facucho-Oliveirapractneurol-2020-002622, author = {Jo{\~a}o Facucho-Oliveira and Daniel Esteves-Sousa and Pedro Espada-Santos and Nuno Moura and Margarida Albuquerque and Ana Margarida Fraga and Sandra Sousa and Pedro Cintra and Luis Mendon{\c c}a and Fernando Pita}, title = {Depression after stroke}, elocation-id = {practneurol-2020-002622}, year = {2021}, doi = {10.1136/practneurol-2020-002622}, publisher = {BMJ Publishing Group Ltd}, abstract = {Stroke treatment has dramatically improved in recent decades. However, although new treatments have reduced its mortality and the severity of its physical and cognitive sequelae, many people still have incapacitating disabilities following a stroke. Depression is the most common psychiatric disorder following stroke; it is important to recognise and treat as it limits motor and cognitive rehabilitation. Antidepressant medication is an effective treatment and can improve adherence to clinically recommended physical and cognitive tasks, thereby enhancing functional remodelling of neuronal pathways and improving rehabilitation outcomes.}, issn = {1474-7758}, URL = {https://pn.bmj.com/content/early/2021/05/13/practneurol-2020-002622}, eprint = {https://pn.bmj.com/content/early/2021/05/13/practneurol-2020-002622.full.pdf}, journal = {Practical Neurology} }